To date, glioma and a subset of breast cancers exhibit PML-dependent self-renewal activity [14, 15], whereas other tumors, such as ovarian cancers or some experimental models of hepatocarcinoma development, exhibit a broad tumor suppressive response upon PML inhibition [11, 12]. The gene discussed is PML; the disease is neoplasm.